S100A8/A9、组蛋白/DNA复合物及cfDNA预测免疫性血栓性血小板减少性紫癜不良结局
该研究检测了94例iTTP患者108次急性发作时的血浆S100A8/A9、组蛋白/DNA复合物、CitH3和cfDNA水平,发现这些标志物均显著升高,且S100A8/A9、组蛋白/DNA复合物和cfDNA升高与器官损伤、凝血病及死亡相关,校正后风险比分别为11.5、10.3和12.8。
要点
- 急性iTTP患者血浆S100A8/A9、组蛋白/DNA复合物、CitH3和cfDNA水平显著高于健康对照。
- S100A8/A9、组蛋白/DNA复合物和cfDNA升高与器官损伤、凝血病和死亡相关。
- 校正年龄和高血压史后,三者升高仍独立预测死亡,风险比分别为11.5、10.3和12.8。
核心结论
- 炎症介质S100A8/A9和NETosis标志物组蛋白/DNA复合物及cfDNA可能参与iTTP发病,并有助于识别急性发作期高死亡风险患者。
研究设计与样本
- 研究纳入94例独特iTTP患者的108次急性发作和健康对照,检测入院血样中S100A8/A9、组蛋白/DNA复合物、CitH3和cfDNA水平。
主要发现
- 急性iTTP患者S100A8/A9中位数84.8 µg/mL(IQR 31.2-157.4),组蛋白/DNA复合物中位数55.7 U/mL(IQR 35.8-130.8),CitH3中位数3.8 ng/mL(IQR 2.2-6.4),cfDNA中位数937.7 ng/mL(IQR 781.3-1420.0),均显著高于健康对照。
- S100A8/A9、组蛋白/DNA复合物和cfDNA升高与器官损伤、凝血病和死亡相关。
临床怎么用
- 急性iTTP发作时可检测血浆S100A8/A9、组蛋白/DNA复合物和cfDNA水平,辅助识别高死亡风险患者以加强监护。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Immune thrombotic thrombocytopenic purpura (iTTP) is a life-threatening blood disorder, primarily resulting from autoantibodies against ADAMTS13. Infection or inflammation often precedes acute iTTP. However, the association of inflammation and inflammatory mediators with disease severity and outcome of acute iTTP is not fully assessed. OBJECTIVES: Here, we determined plasma levels of S100A8/A9, histone/DNA complexes, citrullinated histone H3 (CitH3), and cell-free DNA (cfDNA) in a cohort of 108 acute episodes from 94 unique iTTP patients and healthy controls, and assessed the association of each of these biomarkers with the disease severity and mortality. RESULTS: All acute iTTP patients had significantly increased plasma levels of S100A8/A9 (median 84.8, interquartile range [IQR] 31.2-157.4 µg/mL), histone/DNA complexes (median 55.7, IQR 35.8-130.8 U/mL), CitH3 (median 3.8, IQR 2.2-6.4 ng/mL), and cfDNA (median 937.7, IQR 781.3-1420.0 ng/mL) on the admission blood samples when compared with healthy controls. An increased plasma level of S100A8/A9, histone/DNA complex and cfDNA was associated with organ damage, coagulopathy, and mortality in iTTP. After being adjusted for age and history of hypertension, Cox proportional hazard regression analysis demonstrated that a hazard ratio (95% confidence interval) for an elevated plasma level of S100A8/A9, histone/DNA complexes, and cfDNA was 11.5 (1.4-90.9) (P = .021), 10.3 (2.7-38.5) (P = .001), and 12.8 (3.9-42.0) (P = .014), respectively. CONCLUSION: These results indicate that inflammation or plasma inflammatory mediators such as S100A8/A9 or NETosis markers such as histone/DNA complexes and cfDNA may play a role in pathogenesis of iTTP, which may help stratify patients with a high risk of death during acute iTTP episodes.
引用
- Sui J, Lu R, Halkidis K, et al. Plasma levels of S100A8/A9, histone/DNA complexes, and cell-free DNA predict adverse outcomes of immune thrombotic thrombocytopenic purpura. J Thromb Haemost. 2021. PMID: 33188723. doi:10.1111/jth.15176
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。